Kowa Pharmaceuticals America Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
350
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Kowa Pharmaceuticals America General Information
Description
Provider of healthcare solutions committed to developing and delivering safe, effective solutions in the field of cardiometabolic therapeutics. The company focuses on the acquisition, development, licensing and marketing of pharmaceutical products in the areas of cardiology, pain and migraine, thereby commercializing its current and near-term portfolio of pharmaceutical products and business development activities.
Contact Information
Website
www.kowapharma.com(Operating Subsidiary)
Corporate Office
- 530 Industrial Park Boulevard
- Montgomery, AL 36117
- United States
Corporate Office
- 530 Industrial Park Boulevard
- Montgomery, AL 36117
- United States
Kowa Pharmaceuticals America Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kowa Pharmaceuticals America Comparisons
Industry
Financing
Details
Kowa Pharmaceuticals America Competitors (32)
One of Kowa Pharmaceuticals America’s 32 competitors is Biocon, a Formerly PE-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Jubilant Pharmova | Corporation | Noida, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India |
Kowa Pharmaceuticals America Patents
Kowa Pharmaceuticals America Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2019586-A2 | Acute pain medications based on fast acting diclofenac-opioid combinations | Inactive | 03-May-2006 | ||
| EP-2019586-A4 | Acute pain medications based on fast acting diclofenac-opioid combinations | Inactive | 03-May-2006 | ||
| WO-2007130507-A2 | Acute pain medications based on fast acting diclofenac-opioid combinations | Inactive | 03-May-2006 | ||
| WO-2007130507-A3 | Acute pain medications based on fast acting diclofenac-opioid combinations | Inactive | 03-May-2006 | ||
| WO-2007127207-A2 | Fixed combination dosage forms for the treatment of migraine | Inactive | 25-Apr-2006 | A61K45/06 |
Kowa Pharmaceuticals America Signals
Kowa Pharmaceuticals America FAQs
-
When was Kowa Pharmaceuticals America founded?
Kowa Pharmaceuticals America was founded in 2001.
-
Where is Kowa Pharmaceuticals America headquartered?
Kowa Pharmaceuticals America is headquartered in Montgomery, AL.
-
What is the size of Kowa Pharmaceuticals America?
Kowa Pharmaceuticals America has 350 total employees.
-
What industry is Kowa Pharmaceuticals America in?
Kowa Pharmaceuticals America’s primary industry is Pharmaceuticals.
-
Is Kowa Pharmaceuticals America a private or public company?
Kowa Pharmaceuticals America is a Private company.
-
What is Kowa Pharmaceuticals America’s current revenue?
The current revenue for Kowa Pharmaceuticals America is .
-
Who are Kowa Pharmaceuticals America’s competitors?
Biocon, Jubilant Pharmova, Novartis, Cipla, and Glenmark Pharmaceuticals are some of the 32 competitors of Kowa Pharmaceuticals America.
-
When was Kowa Pharmaceuticals America acquired?
Kowa Pharmaceuticals America was acquired on 01-Jul-2008.
-
Who acquired Kowa Pharmaceuticals America?
Kowa Pharmaceuticals America was acquired by Kowa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process